Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
申请人:Rosentreter Ulrich
公开号:US20060264432A1
公开(公告)日:2006-11-23
The invention relates to compounds of general formula (I), a method for the production thereof and the use thereof as pharmacologically effective substances for a broad medical indication spectrum. Furthermore, selective adenosine receptor ligands, preferably selective adenosine A1-, adenosine A2a- and/or adenosine A2b-receptor ligands are provided for the prophylaxis and/or the treatment of diseases, especially cardiovascular diseases, diseases of the urogenital region, diseases of the respiratory tract, inflammatory and neuroinflammatory diseases, diabetes, especially pancreatic diabetes, neurodegenerative diseases, pain states, cancer as well as liver fibrosis and liver cirrhosis.
Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
申请人:Bayer Aktiengeselischaft
公开号:US07135486B1
公开(公告)日:2006-11-14
This application relates to compounds of formula (I),
wherein R1, R2, R3, and R4 are defined as recited in the claims, or a tautomer, salt, hydrate, or alkoxide thereof. A process for preparing such materials, pharmaceutical compositions containing them, and methods of treating a cardiovascular disorder by administering them to a patient are also disclosed and claimed.